Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 16/20 | 0.66 |
| ▸ | RAB9A | P51151 | 4/20 | 0.43 |
| ▸ | NPC1 | O15118 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | VHL | P40337 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22263324 | 1.00 | AR (0.66) | ARRAB9ANPC1LMNAHTT | |
| SCHEMBL26458261 | 0.99 | AR (0.67) | ARRAB9ANPC1LMNAHTT | |
| SCHEMBL26459201 | 0.92 | AR (0.67) | ARRAB9ANPC1LMNAHTT | |
| SCHEMBL26458268 | 0.89 | AR (0.69) | ARRAB9ANPC1LMNAHTT | |
| SCHEMBL22263246 | 0.89 | AR (0.64) | ARRAB9ANPC1LMNAHTT | |
| SCHEMBL26458194 | 0.88 | AR (0.60) | ARRAB9ANPC1LMNAHTT | |
| SCHEMBL22263288 | 0.88 | AR (0.72) | ARRAB9ANPC1LMNAHTT | |
| SCHEMBL22402900 | 0.87 | AR (0.59) | ARRAB9ANPC1LMNAHTT | |
| SCHEMBL26458197 | 0.86 | AR (0.75) | ARRAB9ANPC1LMNASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL30219487 | 0.85 | AR (0.74) | ARRAB9ANPC1LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024102810-A1 | BI-FUNCTIONAL COMPOUNDS AND METHODS FOR TARGETED UBIQUITINATION OF ANDROGEN RECEPTOR | MONTELINO THERAPEUTICS, INC. (US) | 2024-05-16 | — | — | WO | disclosed |